Pataday and Hctz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pataday (olopatadine hydrochloride) and Hctz (hydrochlorothiazide). Common drug interactions include lip swelling among females and asthma among males.

The phase IV clinical study analyzes what interactions people have when they take Pataday and Hctz. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Pataday?

Pataday has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 8,288 Pataday users. Check the latest studies of Pataday.

What is Hctz?

Hctz has active ingredients of hydrochlorothiazide. It is often used in high blood pressure. eHealthMe is studying from 24,823 Hctz users. Check the latest studies of Hctz.



On Jul, 13, 2026

40 people who take Pataday and Hctz together, and have interactions are studied.

Pataday and Hctz drug interactions.

What are the common drug interactions of Pataday and Hctz, by gender? *:

female:

  1. Lip swelling
  2. Liver disorder (liver diseases)
  3. Lymphocytic infiltration (lymphocyte deposition)
  4. Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
  5. Memory impairment
  6. Migraine (headache)
  7. Nausea (feeling of having an urge to vomit)
  8. Non-hodgkin's lymphoma stage iii (malignant (cancer) cells form in the lymph system- stage iii)
  9. Chronic kidney disease
  10. Hypoaesthesia (reduced sense of touch or sensation)

male:

  1. Asthma
  2. Cough
  3. Abdominal discomfort
  4. Decreased appetite
  5. Disease progression
  6. Drug ineffective
  7. Hepatic enzyme increased
  8. Nausea (feeling of having an urge to vomit)
  9. Nephrogenic anaemia (anaemia due to kidney disease)
  10. Weight decreased

What are the common drug interactions of Pataday and Hctz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Alanine aminotransferase increased
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Aspartate aminotransferase increased
  4. Blood alkaline phosphatase increased
  5. Blood lactate dehydrogenase increased
  6. Blood pressure decreased
  7. Brain injury
  8. C-reactive protein increased
  9. Cerebral haemorrhage (bleeding within the brain)
  10. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

30-39:

n/a

40-49:

  1. Thermal burn (burn by heat)
  2. Influenza like illness
  3. Lip swelling
  4. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  5. Road traffic accident
  6. Scab (a hard coating on the skin formed during the wound healing)

50-59:

  1. Chronic kidney disease
  2. Abdominal pain upper
  3. Dyspepsia (indigestion)
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  7. Psoriasis (immune-mediated disease that affects the skin)
  8. Weight increased
  9. Knee arthroplasty
  10. Upper limb fracture

60+:

  1. Asthma
  2. Cough
  3. Arthralgia (joint pain)
  4. Dyspnoea (difficult or laboured respiration)
  5. Fall
  6. Head injury
  7. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Influenza
  10. Injection site bruising

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 13 people, 32.50%
  2. Pain: 7 people, 17.50%
  3. High Blood Cholesterol: 7 people, 17.50%
  4. Stress And Anxiety: 5 people, 12.50%
  5. Thyroid Diseases: 4 people, 10.00%
  6. Menopause (end of monthly cycles in women): 4 people, 10.00%
  7. Asthma: 4 people, 10.00%
  8. Blood Pressure Abnormal: 4 people, 10.00%
  9. Cardiac Disorder: 4 people, 10.00%
  10. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Pataday and Hctz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pataday and Hctz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pataday:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hctz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pataday and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hctz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on olopatadine hydrochloride and hydrochlorothiazide (the active ingredients of Pataday and Hctz, respectively), and Pataday and Hctz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: